Clover Health Investments Corp. (Class A) (CLOV) exhibits 45.0% gross margins and -29.3% return on invested capital within Health Care (Medical Specialities), balanced against a 24.0x enterprise multiple and 4.8% implied options volatility.
Sustained 45.0% gross profitability converts into -4.4% operating margin and -29.3% ROIC, outpacing sector cost of capital.
ROIC: -29.3% // GM: 45.0%YoY revenue trajectory of +40.3% paired with -2.84% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +40.3% // FCF YLD: -2.84%Altman Z-Score of 3.62 and Piotroski F-Score of 3/9 indicate low near-term refinancing stress.
ALTMAN Z: 3.62 // F-SCORE: 3/9Trading at 24.0x trailing P/E (— Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: —Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $4.58 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical Specialities require continuous execution to defend -4.4% net margins.
NET MARGIN: -4.4% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for CLOV & activate live FRED threshold breach alerts.